GoodRx Holdings, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-09-30; filed 2025-11-04.
0001809519-25-000143
Item 1A. Risk FactorsCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-06.
0001809519-26-000111
Item 1A. Risk FactorsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 123 previous paragraphs and 4 current paragraphs.
1 unchanged; 2 reworded; 1 added; 120 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to the risk factors previously disclosed in our 2025 10-K. For a discussion of
Added paragraphs (1)
Removed paragraphs (120)
Previous report
General economic factors, natural disasters or other unexpected events may adversely affect our business,
Previous report
financial performance and results of operations.
Previous report
Although we only operate in the United States, our business, financial performance and results of operations depend in
Previous report
part on worldwide macroeconomic economic conditions and their impact on consumer spending. Recessionary economic
Previous report
cycles, changing interest rates, volatile fuel and energy costs, inflation, levels of unemployment, conditions in the residential
Previous report
real estate and mortgage markets, access to credit, consumer debt levels, tariffs, government spending freezes, unsettled
Previous report
financial markets and other economic factors that may affect costs of manufacturing prescription medications, consumer
Previous report
spending or buying habits could materially and adversely affect our customers, our consumers, and demand for our
Previous report
offerings. Volatility in the financial markets and deterioration in economic conditions, increasing inflation or increasing
Previous report
unemployment levels has also had and may continue to have a negative impact on consumer spending patterns. Changes
Previous report
and uncertainty can, among other things, reduce or shift spending away from medical treatments, procedures and doctors’
Previous report
In addition, negative national or global economic conditions have adversely affected the PBMs, partner pharmacies and
Previous report
pharma manufacturers we contract with and their associated industry participants, financial performance, liquidity and
Previous report
access to capital, and may continue to impact them. This may affect their ability to renew contracts with us on the same or
Previous report
better terms, which could impact the competitiveness of the discounted prices we are able to offer our consumers. Trade
Previous report
barriers, duties, tariffs, and retaliatory measures by the U.S. and other governments may impact the pharma manufacturers
Previous report
we contract with by increasing their costs of business, which could cause them to decrease their marketing spend on our
Previous report
offerings. All of these factors may be exacerbated by global financial conditions and other geopolitical factors, which could
Previous report
harm our business, financial condition and results of operations.
Previous report
Economic factors such as increased insurance and healthcare costs, commodity prices, tariffs, shipping costs, inflation,
Previous report
higher costs of labor, and changes in or interpretations of other laws, regulations and taxes may also increase our costs and
Previous report
make our offerings less competitive, increase general and administrative expenses, and otherwise adversely affect our
Previous report
Additionally, global public health crises, natural disasters, such as earthquakes and wildfires, and other adverse weather
Previous report
and climate conditions, political crises, such as terrorist attacks, war and other political instability or other unexpected
Previous report
events, could disrupt our operations, internet or mobile networks or the operations of PBMs and their pharmacy networks.
Previous report
For example, our corporate headquarters and other facilities are located in California, which in the past has experienced
Previous report
both severe earthquakes and wildfires. Certain of these events may become more frequent or intense as a result of climate
Previous report
change or other environmental or social pressures. For more information, see our risk factor titled “We are subject to a
Previous report
series of risks related to climate change” previously disclosed in our 2024 10-K. If any of these events occur, our business
Previous report
The impact of healthcare reform legislation and other proposed or future changes impacting the healthcare
Previous report
industry and healthcare spending on us is currently unknown, but may adversely affect our business, financial
Previous report
Our revenue is dependent on the healthcare industry and could be affected by changes in healthcare spending and
Previous report
policy. The healthcare industry is subject to changing political, regulatory and other influences. The Affordable Care Act (the
Previous report
“ACA”), enacted in March 2010, made major changes in how healthcare is delivered and reimbursed, and increased access
Previous report
to health insurance benefits to the uninsured and underinsured population of the United States. The ACA, among other
Showing the first 40 of 120 passages. Open the source sections for the rest.
Reworded paragraphs (2)
Previous wording
Factors" of our 2024 10-K. There have been no material changes to the risk factors previously disclosed in our 2024 10-K,
Current wording
There have been no material changes to the risk factors previously disclosed in our 2025 10-K. For a discussion of
Previous wording
For a discussion of potential risks and uncertainties related to us, see the information included in Part I, Item 1A, "Risk
Current wording
potential risks and uncertainties related to us, see the information included in Part I, Item 1A, "Risk Factors" of our 2025 10-